These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31445896)

  • 1. Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy.
    Tyritzis SI; Wilderäng U; Lantz ΑW; Steineck G; Hugosson J; Bjartell A; Stranne J; Haglind E; Wiklund NP
    Urol Oncol; 2020 Jan; 38(1):5.e1-5.e8. PubMed ID: 31445896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 90-Day readmission after radical prostatectomy-a prospective comparison between robot-assisted and open surgery.
    Wallerstedt Lantz A; Stranne J; Tyritzis SI; Bock D; Wallin D; Nilsson H; Carlsson S; Thorsteinsdottir T; Gustafsson O; Hugosson J; Bjartell A; Wiklund P; Steineck G; Haglind E
    Scand J Urol; 2019 Feb; 53(1):26-33. PubMed ID: 30727795
    [No Abstract]   [Full Text] [Related]  

  • 3. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
    Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
    BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of lymph node yield after pelvic lymph node dissection in men with prostate cancer: a comparison between robot-assisted radical prostatectomy and open radical prostatectomy in the modern era.
    Truesdale MD; Lee DJ; Cheetham PJ; Hruby GW; Turk AT; Badani KK
    J Endourol; 2010 Jul; 24(7):1055-60. PubMed ID: 20575697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy.
    Sebben M; Tafuri A; Shakir A; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Tiso L; De Michele M; Panunzio A; Cerrato C; Brunelli M; Migliorini F; Novella G; De Marco V; Siracusano S; Artibani W; Porcaro AB
    World J Urol; 2020 Nov; 38(11):2799-2809. PubMed ID: 31980875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period.
    Gandaglia G; Trinh QD; Hu JC; Schiffmann J; Becker A; Roghmann F; Popa I; Tian Z; Perrotte P; Montorsi F; Briganti A; Karakiewicz PI; Sun M; Abdollah F
    Eur J Surg Oncol; 2014 Sep; 40(9):1080-6. PubMed ID: 24411705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended pelvic lymph node dissection during radical prostatectomy: comparison between initial robotic experience of a high-volume open surgeon and his contemporary open series.
    Roscigno M; La Croce G; Naspro R; Nicolai M; Manica M; Scarcello M; Chinaglia D; Da Pozzo LF
    Minerva Urol Nefrol; 2019 Dec; 71(6):597-604. PubMed ID: 31144491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review.
    Yuh B; Artibani W; Heidenreich A; Kimm S; Menon M; Novara G; Tewari A; Touijer K; Wilson T; Zorn KC; Eggener SE
    Eur Urol; 2014 May; 65(5):918-27. PubMed ID: 23721959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots.
    Bravi CA; Balestrazzi E; De Loof M; Rebuffo S; Piramide F; Mottaran A; Paciotti M; Sorce G; Nocera L; Sarchi L; Peraire M; Colla'-Ruvolo C; Frego N; Piro A; Ticonosco M; De Backer P; Farinha R; Van Den Bossche H; De Naeyer G; D'Hondt F; De Groote R; Mottrie A
    Eur Urol Focus; 2024 Jan; 10(1):107-114. PubMed ID: 37634969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy.
    Cooperberg MR; Kane CJ; Cowan JE; Carroll PR
    BJU Int; 2010 Jan; 105(1):88-92. PubMed ID: 19549119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open approach, extended pelvic lymph node dissection, and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: a large retrospective study.
    Sebben M; Tafuri A; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Shakir A; De Michele M; Panunzio A; Cerrato C; Tiso L; Novella G; Brunelli M; Migliorini F; De Marco V; Siracusano S; Artibani W; Porcaro AB
    Minerva Urol Nefrol; 2020 Feb; 72(1):72-81. PubMed ID: 31833722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index is an independent predictor of Clavien-Dindo grade 3 complications in patients undergoing robot assisted radical prostatectomy with extensive pelvic lymph node dissection.
    Porcaro AB; Sebben M; Tafuri A; de Luyk N; Corsi P; Processali T; Pirozzi M; Rizzetto R; Amigoni N; Mattevi D; Cerruto MA; Brunelli M; Novella G; De Marco V; Migliorini F; Artibani W
    J Robot Surg; 2019 Feb; 13(1):83-89. PubMed ID: 29737495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Peritoneal Fixation (PerFix) on Lymphocele Formation in Robot-assisted Radical Prostatectomy with Pelvic Lymphadenectomy: Results of a Randomized Prospective Trial.
    Student V; Tudos Z; Studentova Z; Cesak O; Studentova H; Repa V; Purova D; Student V
    Eur Urol; 2023 Feb; 83(2):154-162. PubMed ID: 36041934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pelvic lymph node dissection in robot-assisted laparoscopic radical prostatectomy: safety and adequacy in introductory series].
    Sunada T; Kobayashi T; Shibasaki N; Okada Y; Negoro H; Terada N; Yamasaki T; Matsui Y; Inoue T; Kamba T; Ogawa O
    Hinyokika Kiyo; 2015 Mar; 61(3):89-93. PubMed ID: 25918265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolic complications in 3,544 patients undergoing radical prostatectomy with or without lymph node dissection.
    Tyritzis SI; Wallerstedt A; Steineck G; Nyberg T; Hugosson J; Bjartell A; Wilderäng U; Thorsteinsdottir T; Carlsson S; Stranne J; Haglind E; Wiklund NP;
    J Urol; 2015 Jan; 193(1):117-25. PubMed ID: 25158271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy.
    Morizane S; Honda M; Shimizu R; Tsounapi P; Teraoka S; Yumioka T; Yamaguchi N; Kawamoto B; Iwamoto H; Hikita K; Takenaka A
    Int J Clin Oncol; 2022 Apr; 27(4):781-789. PubMed ID: 35076818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term results after robot-assisted laparoscopic radical prostatectomy compared to open radical prostatectomy.
    Wallerstedt A; Tyritzis SI; Thorsteinsdottir T; Carlsson S; Stranne J; Gustafsson O; Hugosson J; Bjartell A; Wilderäng U; Wiklund NP; Steineck G; Haglind E;
    Eur Urol; 2015 Apr; 67(4):660-70. PubMed ID: 25308968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium.
    Lescay H; Abdollah F; Cher ML; Qi J; Linsell S; Miller DC; Montie JE; Peabody J; Kaffenberger S; Morgan T; Loeb A; Lane BR;
    Urol Oncol; 2020 Apr; 38(4):198-203. PubMed ID: 31740331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.